2002 OPPS RATES POSTPONED - PRESS RELEASE FROM CMS PUBLIC AFFAIRS
January 2, 2002 --
DEPARTMENT OF HEALTH & HUMAN SERVICES
Centers for Medicare & Medicaid Services
Room 303-D
200 Independence Avenue, SW
Washington, DC 20201
Public Affairs Office
FOR IMMEDIATE RELEASE
Contact: CMS Public Affairs
Tuesday, Dec.18, 2001
(202) 690-6145
HHS TO POSTPONE IMPLEMENTATION
OF OUTPATIENT PROSPECTIVE PAYMENT REGULATION
The Department of Health and Human Services' Centers for Medicare & Medicaid Services (CMS) will issue a notice in the Federal Register before Dec. 31, 2001, announcing that the 2002 hospital outpatient prospective payment system rates set to go into effect on Jan. 1, 2002, will be postponed while CMS continues to review the rates and codes announced in November of this
year.
"Our goal is to provide the best service possible to Medicare beneficiaries, hospitals and doctors, and we believe this action will help CMS meet that goal," said HHS Secretary Tommy G. Thompson.
Since issuing the final regulation on Nov. 30, CMS discovered a number of technical miscalculations in the assignment of the cost of certain new technology devices to related procedure codes. Once the corrections are made, CMS will do a thorough review of all outpatient codes with medical experts and again review the data to insure there are no additional
calculation errors. The revised rates and codes will then be published in the Federal Register. There are more than 300 ambulatory payment classification codes (APCs) for outpatient procedures and 53 APCs that involve new technology devices.
"I expect this to be a one time glitch in the system," said CMS Administrator Tom Scully. " I believe a review of all our outpatient codes, and the entire program, is best served by this delay. We do not want to undercut patient or provider confidence in the Medicare program.
“We also appreciate the bipartisan, bicameral support for our efforts to delay, as outlined in the letter from the key congressional committee chairs and ranking members,” said Scully.
Hospitals will be paid for outpatient services they provide to Medicare beneficiaries at the 2001 rates until CMS has completed its review, but such review will not be extended beyond March 31, 2002.
About C. R. Bard, Inc.
C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of healthcare products. Bard Endoscopic Technologies, headquartered in Billerica, MA, is a division of C. R. Bard, Inc. (NYSE-BCR), specializing in the field of gastroenterology. For more than ten years, Bard Endoscopic Technologies (formerly Bard Interventional Products) has been developing minimally invasive diagnostic and therapeutic products used in conjunction with procedures requiring flexible endoscopy. Visit the company website at www.crbard.com.
Find a Physician
